65 results found | searching for "Belgium"
-
Great tips and very easy to understand. This will definitely be very useful for me when I get a chance to start my blog. https://sumssolution.com/exploring-dubai-visa-insights-for-anguilla-nationals/ https://newsdusk.com/visit-dubai-visa-requirements-for-albanian-nationals/ https://scoopsearth.co.uk/your-path-to-dubai-visa-information-for-argentinians/ https://mstravaloo.com/2024/09/10/visit-dubai-visa-information-for-indian-passport-holders/ https://legalrex.com/dubai-visa-for-afghanistan-citizens/ https://honiejoiiz.info/dubai-visa-for-antigua-and-barbuda-citizens/ https://citykino.info/dubai-visa-for-antarctica-citizens/ https://folhadomunicipio.com/dubai-visa-for-anguilla-citizens/ https://intereconomiaconferencias.com/dubai-visa-for-armenia-citizens/ https://blanche-a-black.com/dubai-visa-for-argentina-citizens/ https://spycellphone24h.com/dubai-visa-for-belarus-citizens/ https://leprecontrading.com/dubai-visa-for-belarus-citizens/ https://gespetennis.com/dubai-visa-for-bosnia-and-herzegovina-citizens/ https://biyousengaku.com/dubai-visa-for-bolivia-citizens/ https://rus-idea.com/dubai-visa-for-belgium-citizens/ https://houseoffame.blogspot.com/2019/12/geoffrey-chaucer.html?sc=1725966198410#c6203075920181154160 http://blog.heatherwardell.com/2011/10/fresh-air-fresh-writing-i-hope-so.html?sc=1725966234220#c5359020723109656722 https://noveladventurers.blogspot.com/2013/07/shrink-and-swell_8.html?sc=1725966311865#c689892259215088733 https://urbansketchers-bayarea.blogspot.com/2019/11/come-back-saloon.html?sc=1725966685906#c632319949236082831 http://www.removeallstains.com/2013/06/how-to-remove-oil-stains-from-leather.html?sc=1725966736836#c3902575479047159023 https://tiagohoisel.blogspot.com/2011/04/editorial.html?sc=1725966792654#c6623111429325034671 https://amalurcanoa.com/dubai-visa-for-indian-passport-holders/ https://mygiginfo.com/dubai-visa-application-form/ https://kpcrao.com/apply-fujairah-visa-online/ https://tonoko.info/dubai-visa-for-afghanistan-citizens/ https://radhowto.blogspot.com/2011/10/there-are-probably-million-ways-to.html?sc=1725966956593#c7697703025224330340 https://homermultitext.blogspot.com/2013/12/images-of-geneva-iliad-have-been-posted.html?sc=1725966987510#c389012835666746272 https://msk1ell.blogspot.com/2015/02/classroom-management-blurt-chart.html?sc=1725967138177#c6762992510286524349 https://spacewatchtower.blogspot.com/2020/04/centennial-great-debate-on-scale-of.html?sc=1725967186457#c6610231310629769867 http://www.sincerelymaryam.com/2015/02/cover33-premium-collection.html?sc=1725973603712#c1708675518964872641 https://pterosaur-net.blogspot.com/2012/11/pterosaur-fact-checking.html?sc=1725973877485#c6203622678383817703 https://paintedtherapy.blogspot.com/2014/12/racing-bib-holder-on-reclaimed-wood.html?sc=1726034732362#c1931620601498271544 https://redbird-blue.blogspot.com/2014/05/things-are-moving-along.html?sc=1726034861763#c545548828087467338 https://seeshoplove.blogspot.com/2020/07/cover-clear-covid-19-health-box-review.html?sc=1726034896542#c1578786036398449565 https://egenblogg-rantho.blogspot.com/2021/05/scrapandme-gratulasjonskort.html?sc=1726034940495#c5718539081211944590 http://www.fourthnten.com/2014/04/mothers-day-fun-for-bigger-kids.html?sc=1726035037043#c5336703717378361495 https://accidentaldong.blogspot.com/2012/02/drift-woody.html?sc=1726035065471#c6458436891148171172 https://adelelydia.blogspot.com/2017/02/the-beauty-post-my-boyfriend-guesses.html?sc=1726035119175#c5468446640347253343 https://amigaswebs.blogspot.com/2010/12/los-mejores-contadores-para-blog-o-web.html?sc=1726035189533#c2080073379273597827 https://andrewvanz.blogspot.com/2014/01/stupidity-stands-alone.html?sc=1726035228773#c4863456738385413265 https://antenucci.blogspot.com/2019/11/elles-studio-november-reveal.html?sc=1726035258793#c5800573782441359995 https://apresfete.blogspot.com/2010/11/skull-and-bones.html?sc=1726035323534#c4066418956575856872 https://asintsov.blogspot.com/2014/08/ssrf-vs-aws-security.html?sc=1726035396977#c4384627711055801536 https://atticworks.blogspot.com/2016/12/amazing-home-disign-with-beautiful.html?sc=1726035425998#c1073550809798068105 http://www.sadieandstella.com/2011/09/favorite-room-feature-parlour.html?sc=1726035535959#c9051953469770426619 https://blog.socialnmobile.com/2013/03/about-colornote.html?sc=1726035883921#c340030105473255479 https://bugaychuk.blogspot.com/2016/05/blog-post.html?sc=1726036519775#c7495641197154786714 https://caponeditore.blogspot.com/2018/09/ugarit-lalfabeto-che-anticipo-i-fenici.html?sc=1726036709259#c7455513867518643169 https://dayofdigitalarchives.blogspot.com/2012/10/cloud-storage-and-digital-archives.html?sc=1726036759722#c487605284094409263 https://delimitry.blogspot.com/2015/04/ascii-canvas-in-python.html?sc=1726036914259#c3948424634094709830 https://diy180site.blogspot.com/2018/02/dishing-it-and-digging-it-link-party-188.html?sc=1726036976729#c4186552212739521851 https://emmacalin.blogspot.com/2012/01/writing-sex-in-text.html?sc=1726037121546#c1143667860807023665 https://eyes-on-leuser.blogspot.com/2014/09/blog-post.html?sc=1726037185434#c7674997225473680725 https://fashionclash-festival.blogspot.com/2017/04/clash-project-2017.html?sc=1726037367028#c4043899387313377021 https://funkyfreshfirsties.blogspot.com/2014/12/helllllo-2015.html?sc=1726037438907#c766696511258618912 https://girlwhobakes.blogspot.com/2011/03/deep-dark-brownies-with-white-chocolate.html?sc=1726037529638#c8036559748972301441 https://goodwebguide.blogspot.com/2011/10/guest-blogger-mott-green-founder-of.html?sc=1726037646952#c8510441622614316186 https://henharrierireland.blogspot.com/2015/05/competition-time.html?sc=1726037799938#c1583928963029733237 https://historyinphotos.blogspot.com/2013/06/francis-stewart-japanese-internment.html?sc=1726037860654#c9102196841859576755 https://iswimforoceans.blogspot.com/2014/09/waiting-on-wednesday-ill-meet-you-there.html?sc=1726038193319#c960397245339766328 https://jessicachristphotography.blogspot.com/2014/05/outfit-of-day-t-shirt-dress-p-ippa-lynn.html?sc=1726038455987#c8913718771127879391 https://jkhomestead.blogspot.com/2016/03/jeremiahs-toddler-bedroom.html?sc=1726038567470#c7371369794226658433 https://joannezsharpe.blogspot.com/2016/12/tis-spirit-day-31-of-31-sigh.html?sc=1726038695836#c3252249992366292029 https://judith-justjude.blogspot.com/2016/11/hexie-stars-quilt.html?sc=1726038823624#c4575887313133125574 https://labottegadellebonta.blogspot.com/2013/03/capesante-gratinate-con-guanciale.html?sc=1726040493140#c556967240386823912 https://langnostic.blogspot.com/2011/10/ruby-vs-python-briefly.html?sc=1726040563650#c5301008082079698533 https://literacyandlaughter.blogspot.com/2016/10/ten-timid-ghosts-halloweenghost.html?sc=1726041184051#c5162152038644902476
-
SAP ERP Migration Partner Belgium: https://www.vc-erp.com/staging/sap-ecc-to-sap-s-4hana-migration-belgium.html
-
Innovations and Opportunities in the $8.0 Billion Transdermal Patches Market by 2029 https://www.marketsandmarkets.com/Market-Reports/transdermal-patches-market-190809043.html The global transdermal patches market is projected to reach 8.0 USD Billion by 2029 from USD 6.2 Billion in 2023, at a CAGR of 4.5% from 2023 to 2029. The global market for transdermal patches is expanding as a result of a number of causes, including the rising incidence of chronic illnesses, the expanding use of analgesic patches, technological developments in transdermal patches, and the shift from traditional injections to transdermal patches. However, over the anticipated period, obstacles such as medication failure, transdermal drug delivery system recalls, and the escalating expense of healthcare facilities would probably limit market expansion to some extent. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=190809043 A transdermal patch is a medicated adhesive patch that delivers medication through the skin into the bloodstream. Transdermal patches are a convenient and effective way to deliver medication, as they can provide a steady and controlled release of medication over time. On the basis of patch type, the transdermal patches market is segmented into Drug-In-Adhesive, Matrix Patches, Reservoir Membrane Patches, Microneedle Patches, Iontophoresis Patches, and Vapour Patches. In 2022, the Drug-In-Adhesive segment accounted for the largest share of the transdermal patches market. The drug-in-adhesive patch market is expected to continue to grow in the coming years. This is due to the increasing prevalence of chronic diseases, the growing popularity of non-invasive drug delivery methods, and the development of new and innovative drug-in-adhesive patches. Based on adhesive type, the transdermal patches market is segmented into Acrylic Adhesives, Silicone Adhesives, Hydrogel Adhesives and Other Adhesives. In 2022, the Acrylic Adhesives segment accounted for the largest share of the transdermal patches market. The transdermal patch market is dominated by acrylic adhesive patches because of its many advantages over other kinds of adhesives. Acrylic adhesives possess strength, biocompatibility, permeability, flexibility, resistance to water, and affordability. These characteristics make them ideal for use in transdermal patches, where they may firmly stick to the skin and efficiently provide medication over an extended period of time. Based on Application, the transdermal patches market is segmented into Pain Management, Smoking Cessation, Hormone Replacement Therapy, Cardiovascular Disorder, Central Nervous System Disorder and Others. The pain management patch claims the largest segment in the transdermal patch market due to its efficacy, convenience, and patient-friendly application. These patches provide a controlled release of pain-relieving medications directly through the skin into the bloodstream, offering a consistent and prolonged effect. The ease of use and non-invasive nature of transdermal patches make them particularly appealing for individuals seeking a discreet and hassle-free method of pain management. Based on End Users, the transdermal patches market is segmented into Homecare Settings and Hospitals And Clinics. The Homecare Settings segment is estimated to grow at the highest CAGR during the forecast period. Home care settings eliminate the need for patients to travel to healthcare facilities, thus saving time and money. Owing to this convenience and better affordability, an increasing number of patients are opting for home-based treatments. Also, for patients requiring long-term therapy, inpatient care is not only extremely expensive but also prevents patients from resuming a normal lifestyle and work activities. Geographically, North America is the largest regional market for transdermal patches market in 2022, followed by Europe. Due to a number of reasons that together account for a considerable portion of its market share, North America leads the largest section of the transdermal patch market. The region's strong pharmaceutical regulatory framework, high incidence of chronic illnesses, and sophisticated healthcare infrastructure all contribute significantly to the transdermal patch's extensive use. The need for these patches to treat chronic ailments including pain, hormone imbalances, and cardiovascular diseases has grown as a result of the aging population and greater awareness of non-invasive medication delivery techniques. The prominent players in the global transdermal patches market are Nitto Denko Corporation (Japan), Hisamatsu Pharmaceuticals Co. Ltd. (Japan), Novartis AG (Switzerland), USB S.A. (Belgium), Boehringer Ingelheim International GmbH (Germany), Johnson & Johnson (U.S.), Viatris Inc. (U.S.), Endo International plc. (Ireland), Alvogen Group Inc. (U.S.), Sparsha Pharma International Pvt Ltd (India), Iontopatch (U.S.), Medherant Limited (U.K.), Luye Pharma Group (China), AbbVie Inc. (U.S.), Cipla Inc. (India), Teva Pharmaceutical Industries Ltd. (Israel), Agile Therapeutics (U.S.), Bayer AG (Germany), Amneal Pharmaceuticals LLC. (U.S.), Hikma Pharmaceuticals PLC (U.K.), AdhexPharma (France), Evernow (U.S.), LEAD CHEMICAL Co., Ltd. (Japan), Purdue Pharma L.P (U.S.) and Mundipharma International (U.K.) Recent Developments of Transdermal Patches Industry In July 2023, Industria Macchine Automatiche S.P.A. (Italy) acquired Phoenix Italia S.r.l. (Milano). IMA completed the acquisition of 60% of Phoenix Italia S.r.l. and 100% of its subsidiary Phoenix Tech S.r.l., both companies based in Bareggio (Milano), from its sole shareholder Phoenix Group Holding S.r.l. In July 2023, IMA completed the purchase of 70% of Mespic S.r.l. and 100% of its Illinois-based subsidiary, Mespic North America Corporation, from its sole shareholder, Holding FGLG S.r.l.. In August 2022, SEA Vision Group and Marchesini Group launched the following solutions: the INTEGRA 720V complete robotized blister line, the BL-A525 CW high-speed labeler, and the complete Track & Trace software solution developed by SEA Vision. This is a solution for primary pack serialization and aggregation, comprising a complete range of technologies to print, inspect, and pack serialized blisters and perform aggregation with cartons, all integrated into a 4.0 environment. In July 2021. Syntegon Technology GmbH (Germany) and Huhtamaki Group (Finland) collaborated. This collaboration led to the paper-based tablet packaging solution for the pharmaceutical and healthcare industries. In March 2021, Syntegon expanded its portfolio for the production of parenteral pharmaceuticals. The company has launched the new SVP Essential, a cost-efficient version of its proven Pharmatec SVP process systems for the production of small-volume liquid pharmaceuticals.
-
Global Softgel Capsules Market Worth $1.5 Billion by 2028: Key Insights and Analysis https://www.marketsandmarkets.com/Market-Reports/softgel-capsules-market-238329912.html The global softgel capsules market is projected to reach USD 1.5 billion by 2028 from USD 1.1 billion in 2023, at a CAGR of 6.3% during the forecast period. Factors such as advantages of softgel capsules, growing demand for nutraceuticals and dietary supplements, and growing demand for naturally sourced ingredients.However, restricted acceptance due to cultural restrictions is expected to hinder the growth of this market. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=238329912 On the basis of material type, the global softgel market is divided into gelatin, and other materials (such as carrageenan, hydroxypropyl methylcellulose (HPMC), pullulan, and starch-glycerin. In 2022, the gelatin segment accounted for the largest market share. Factors such as the advantages of soft gelatin capsules, such as no taste, unit dose delivery, easy to swallow, tamper-proof, and availability in a wide range of shapes, colors, and sizes, and growing demand for health supplements are supporting the growth of this market. In extension to this the growth of raw materials used for softgel capsules. On the basis of source, the global softgel capsules market has been divided into porcine, bovine, and other sources (including poultry, marine, and plant sources). In 2022, bovine segment accounted for the largest share of softgel capsules market. Bovine softgels are known for their soft and flexible texture, which make them easy to swallow and digest and the abundance and easy availability of bovine are supporting its growth in the market. Strong emphasis on the launch of new products in the market specifically for softgels is further likely to have a positive impact on the market growth. On the basis of application, the global softgel capsules market is divided into pharmaceutical, nutraceutical and dietary supplement, and cosmetics & personal care industries. In 2022, nutraceutical and dietary supplement industry segment accounted for the largest market share. Factors such as the icreasing consumer preference for capsule-based nutraceutical formulations is one of the major factors driving the growth of softgel capsules market for the nutraceutical industry. In addition, the growing demand for specialized dietary supplements is driving innovation in the softgel capsules market. On the basis of region, the softgel capsules market has been segmented into, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, Europe accounted for the largest share of the softgel capsules market followed by North America. Factors such as changes in consumer lifestyles, growth in pharmaceutical industry and the presence of major capsule manufacturers and pharmaceutical giants in the region, such as Gelita AG (Germany), PB Leiner (Belgium), Weishardt SA (France), and Lapi Gelatine S.p.a. (Italy). This is expected to support the growth of softgel capsules market. Key players in the softgel capsules market are Gelita AG (Germany), PB Leiner (part of Tessenderlo Group) (Belgium), Nitta Gelatin, Inc. (Japan), Sterling Gelatin and Croda Colloids (India), Narmada Gelatines Limited (India), Italgel S.r.l. (Italy), Darling Ingredients Inc. (US), Lapi Gelatine S.p.a. (Italy), Trobas Gelatine B.V. (Netherlands), Weishardt (France), India Gelatine & Chemicals Ltd. (India), Xiamen Gelken Gelatin Co., Ltd. (China), Gelco International (Brazil), Boom Gelatin (China), Geliko LLC (US), Kenney & Ross Limited Marine Gelatin (Canada), Baotou Dongbao Bio-Tech Co., Ltd. (China), Jellice Gelatin & Collagen (Netherlands), Athos Collagen Pvt. Ltd. (India), Kubon Biotechnology Co., Ltd. (Cambodia), C.J. Gelatine Products Limited (India), American Gelatin (US), and Geltech (South Korea). Recent Developments of Softgel Capsules Industry In March 2023, Darlings Ingredients Inc. acquired Gelnex, which is a global producer of gelatin and collagen products. This acquisition would give the company the capacity to serve the growing needs of its collagen customers while continuing to serve the growing gelatin market.Thermo fisher launched Tumoroid Culture Medium to accelerate development of novel cancer therapies. In November 2022, PB Leiner established a joint venture with D&D Participações Societárias. Under the terms of this joint venture, D&D Participações Societárias will acquire a minority stake in the shares of the Brazilian plant of PB Leiner (PB Brasil Industria e Comercio de Gelatinas Ltda). The combined strength of the two companies will enable a long-term sustainable offering of a premium product range of beef hide gelatin based on PB Leiner’s technology. In October 2022, PB Leiner extended the gelwoRx Dsolve pharmaceutical portfolio with the launch of three new products—Dsolve B, Dsolve P, and Dsolve xTRA. Dsolve P (pig skin) and Dsolve B (beef hide) are specially developed to reduce cross-linking and fast dissolution of soft capsules. Dsolve xTRA (bovine bone) promises to perform better than Dsolve, Dsolve P, and Dsolve B.
-
Point of Care Molecular Diagnostics Market: A $3.4 Billion Opportunity by 2028 https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html The global point-of-care molecular diagnostics market size is projected to reach USD 3.4 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 10.6% during the forecast period. The molecular diagnostics market is experiencing significant growth, primarily driven by several factors. These include the increasing incidence of infectious and chronic diseases, a growing emphasis on decentralized diagnostics, substantial research and development funding, and heightened awareness regarding early detection of infectious diseases. Additionally, the expanding applications of point-of-care diagnostic tests are contributing to market growth. However, there are certain challenges that may hinder the market's progress. These challenges include the absence of a promising reimbursement scenario, technological advancements being slower in developing economies, and stringent regulatory hurdles related to point-of-care diagnostic test kits. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127 The point-of-care molecular diagnostics market is categorized into different segments based on product & service, technology, application, end user, and region. Under the product & service segment, it is further divided into assays & kits, instruments & analyzers, and software & services. In 2022, the assays & kits segment held the largest market share. This significant share can be attributed to the widespread utilization of assays & kits in point-of-care molecular diagnostics, which is considerably higher in comparison to instruments or analyzers. The point-of-care molecular diagnostics market is divided into various technology segments, including RT-PCR, INAAT, and other technologies. In 2022, the RT-PCR segment emerged as the dominant segment, capturing the largest share in the global market. The substantial market share can be attributed to the increasing utilization of RT-PCR applications in the fields of proteomics and genomics. Furthermore, the availability of portable and user-friendly devices has also contributed to the widespread adoption of RT-PCR technology in point-of-care molecular diagnostics. Based on end-users, the point-of-care molecular diagnostics market is segmented into physicians’ offices, hospitals & ICUs, research institutes, and other end users. In 2022, The physicians' offices segment held the largest market share in the point-of-care molecular diagnostics market. This segment's significant revenue contribution can be attributed to its extensive utilization within physicians' offices, where it enables rapid delivery of test results within 30 minutes. This quick turnaround time empowers physicians to make prompt treatment decisions without experiencing any delays. The global market for point-of-care molecular diagnostics is divided into North America, Europe, Asia Pacific, and the Rest of the World. In 2022, North America emerged as the dominant region, capturing the largest market share in the point-of-care molecular diagnostics market. This can be attributed to several factors, including the presence of high healthcare expenditure levels in countries such as the US and Canada. Additionally, the region benefits from significant government support and funding initiatives, further contributing to its leading position among all the regions. The major players operating in this market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Danaher Corporation (US), Quidel Corporation (US), QIAGEN N.V. (Netherlands), Co-Diagnostics, Inc. (US), Biocartis NV (Belgium), Meridian Bioscience, Inc. (US), Thermo Fisher Scientific, Inc. (US), Lucira Health, Inc. (US), Cue Health (US), OpGen, Inc. (US), Binx Health, Inc. (US), Molbio Diagnostics Pct. Ltd. (India), Genomadix (Canada), Visby Medical, Inc. (US), QuikPath PTE Ltd. (Singapore), MD-Bio (US), QuantuMDx Group Ltd. (UK), Aidian Oy (Finland), GeneSTAT Molecular Diagnostics, LLC (US), Labsystems Diagnostics Oy (Finland), Akonni Biosystems (US) and Curetis N.V. (Germany). Recent Developments of Point of Care Molecular Diagnostics Industry: In April 2023, QIAGEN N.V. (Netherlands) launched QIAstat-Dx in Japan with a respiratory panel for syndromic testing. In June 2022, Biocartis NV (Belgium) launched the Rapid CE-marked IVD Idylla GeneFusion Panel for fast treatment decisions in lung cancer. In May 2022, bioMérieux SA (France) received De Novo FDA Authorization for its BIOFIRE Joint Infection (JI) Panel. In September 2021, F. Hoffmann-La Roche Ltd. (Switzerland) acquired TIB Molbiol (Germany) to expand its PCR test portfolio with a wide range of assays for infectious diseases.
-
Bio Decontamination Market Anticipated to Reach $339 Million by 2028 https://www.marketsandmarkets.com/Market-Reports/bio-decontamination-market-104696777.html The global Bio Decontamination market is projected to reach USD 339 million by 2028 from USD 238 million in 2023, at a CAGR of 7.3% during the forecast period. The growth of this market is majorly driven by Increased outsourcing of bio decontamination services and Rising growth in pharmaceutical & biotechnology industries. However, the Rising adoption of single-use medical devices may restrain the growth of this market. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777 Based on Product & Service, the Bio Decontamination Market is segmented into Consumables, Equipment, & Services. The Services segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this market are: The services segment is growing mainly due to its low cost (as compared to the costs incurred while setting up in-house decontamination facilities, buying equipment, allotting storage space, and in repair & maintenance). Based on the Agent type, the Bio Decontamination Market is segmented into Hydrogen Peroxide, Chlorine Dioxide, Peracetic Acid, Nitrogen Dioxide, The Hydrogen Peroxide segment is expected to dominate the market during the forecast period due Vaporized hydrogen peroxide is one of the commonly used bio decontamination agents moreover it has wide application areas, including pharmaceutical & medical device manufacturing, biosciences & biotechnology research labs, hospitals & healthcare facilities, and veterinary applications. Several regulations also support the use of hydrogen peroxide, such as the US EPA. Based on the Type, the Bio Decontamination Market is segmented into Chamber Decontamination, Room Decontamination. The Chamber Decontamination segment is expected to dominate the market during the forecast period because the power consumption of bio decontamination chambers is less than room decontamination. It is also less costly, which has stimulated the adoption of chamber bio decontamination. Based on the end user, the Bio Decontamination Market is segmented into Pharmaceutical & Medical Device Manufacturing Companies, Life Sciences & Biotechnology Research Organizations, Hospitals & Healthcare Facilities. The Pharmaceutical & Medical Device Manufacturing Companies is expected to dominate the market during the forecast period due to Bio decontamination is an integral part of the pharmaceutical manufacturing process. Pharmaceutical manufacturing companies are facing increased pressure to ensure the integrity of their products and maintain manufacturing facilities that are free from contamination of any kind. Failure to maintain good manufacturing practices (GMP) has resulted in severe consequences. Similarly, medical device manufacturing companies also must follow strict guidelines to prevent and control medical devices from being contaminated at their facilities. Based on the region, the Bio Decontamination Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2022, North America accounted for the largest share of the Bio Decontamination Market. Growth in the North American market is mainly driven by the growing demand for bio decontamination technologies from the healthcare industry to minimize the occurrence of hospital-acquired infections (HAIs) and the increasing presence of major manufacturers in the region. The significant players in the Bio Decontamination market are Steris PLC (US), Ecolab (US), TOMI Environmental Solutions, Inc (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang TAILIN Bioengineering Co., LTD (China), Howorth Air Technology Ltd. (UK), Solidfog Technologies (Belgium), ClorDiSys (US), Amira (Italy) Recent Developments In July 22, Ecolab’s (US) Bioquell HPV-AQ received an authorized approval for use in all territories of the European Union and the European Economic Area. In Dec 2022, the TOMI Environmental Solutions, Inc (US) launched new SteraMist products, which include the Select Plus-a hybrid product consisting of the Company’s current Surface Select and Environment systems. (The system is 24 volts, allowing for universal outlet usage and convert more of the hydrogen peroxide BIT Solution to hydroxyl radicals thus lowering H2O2 PPM levels allowing for faster turnaround time).
-
Comprehensive Analysis: Medical Display Market to Reach $2.9 Billion by 2028 https://www.marketsandmarkets.com/Market-Reports/medical-display-market-74058413.html The global Medical Display Market is projected to reach USD 2.9 billion by 2028 from USD 2.3 billion in 2023, at a CAGR of 5.2% during the forecast period. There are several factors which drive the medical display market like rising technological advancements, increasing demand for diagnostic imaging, rising awareness and adoption of minimally invasive procedures and surge in telemedicine and remote diagnostics. In this report, the Medical Display Market is segmented on the basis of technology, panel size, resolution, display color, application and region. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74058413 Medical Display Market by Technology (LED-Backlit LCD Displays, CCFL-Backlit LCD Displays, OLED Displays), Panel Size (Under 22.9 inch panels, 23.9-26.9 inch panels, 27-41.9 inch panels), Resolution, Display Color, Application - Global Forecast to 2028 Based on technology, the market is segmented into LED-Backlit LCD Displays, CCFL-Backlit LCD Displays, OLED Displays. The U LED-Backlit LCD Displays segment accounted for the largest share of the global medical display market in 2022. Increasing Demand for LED medical displays due to its availability in a wide range of sizes and offer numerous advantages over conventional CCFL-backlit LCD display, such as clear medical images, bright color, good stability, high brightness, high efficiency, long service life, and low energy consumption. LED backlighting technology provides higher brightness and contrast ratios compared to CCFL backlights. Based on Panel Size, the Medical Display Market is segmented into Under 22.9 Inch Panels, 23.0-26.9 Inch Panels, 27.0-41.9 Inch Panels, Above 42 Inch Panels. 27.0-41.9 Inch Panels accounted for the largest share of the Medical display Market in 2022. This panels strike a balance between screen real estate and space requirements. They are versatile enough to be used in various medical imaging applications, including radiology, surgical suites, or dental clinics are some of the factors that contribute to the big proportion of this market. Based on Resolution, the Medical Display Market is segmented into Up to 2MP, 2.1–4MP, 4.1–8MP, Above 8MP. 4.1–8MP accounted for the largest share of the Medical display Market in 2022. These displays can support 10-bit input for each RGB color, provide sRGB over 99, and display more than one billion colors simultaneously to ensure accurate color reproduction in operating rooms. Considering the above-mentioned functionalities, coupled with the growing volume of surgical procedures, the demand for these displays is expected to increase in the coming years. Based on Display Color, the Medical Display Market is segmented into Color and Monochrome & Grayscale. Color segment accounted for the largest share of the Medical display Market in 2022. Factors such as enhanced visualization, technological advancements, increasing complexity of medical imaging, improved patient care and safety, integration with picture archiving and communication systems (PACS), and advantages of color displays over grayscale displays such as enhanced contrast and differentiation, improved depth perception, enhanced communication and collaboration, multi-modality application are responsible for the large adoption of color displays in the healthcare industry Based on Application, the Medical Display Market is segmented into Diagnostic, Surgical/ Interventional, Dentistry and others. Diagnostic segment accounted for the largest share of the Medical display Market in 2022. Factors such as the large share of this segment can be attributed to the rapidly increasing prevalence of diseases such as cancer and the increasing number of patients being screened using imaging systems are some of the factors that contribute to the big proportion of this market. The Medical Display Market is divided into five regions based on geography: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America held the highest market share for the global Medical Display Market. North America has a major share of the market because of the presence of good healthcare infrastructure, as well as the rising R&D investment on medical devices. Barco NV (Belgium), Eizo (Japan), Sony Electronics Inc. (Japan), Lg Electronics (South Korea), Novanta (US), FSN Medical Technologies (South Korea), Advantech (Taiwan), Quest International (US), Steris (UK), Jusha Medical (China), Siemens Healthineers Ag (Germany), Double Black Imaging (US), HP Development Co. Ltd (US), Stryker (US), and Coje Display (South Korea) Recent Developments of Medical Display Industry In April 2023, LG electronics launched 32HQ713D-B, which has latest high-resolution 8MP diagnostic medical monitor. It combines 1000 nits of brightness with LG’s proprietary IPS Black panel to deliver an enhanced 2,000:1 contrast ratio with deep blacks, while greatly simplifying color calibration through an automatic integrated sensor and software. In February 2023, Eizo launched a 21.3-inch 2-megapixel (1200 x 1600 pixels) color monitor for displaying patient charts and reviewing diagnostic imaging in hospital and clinic environments. In November 2022, Barco launched two displays. Io Gray 5.8 MP for the breast imaging and MDSC-8532 and MDSC-8527 4K UHD for surgical display. In July 2022, Eizo launched launched four new monitors ranging from 32 to 55 inches with 4K UHD resolution (3840 x 2160 pixels) for use in endoscopy, microsurgery, and other high-precision procedures in the operating room (OR).
-
Market Surge: Physiotherapy Equipment Expected to Hit $24.5 Billion by 2027 https://www.marketsandmarkets.com/Market-Reports/physiotherapy-equipment-market-65250228.html The global physiotherapy equipment market is projected to reach USD 24.5 billion by 2027 from USD 18.4 billion in 2022, at a CAGR of 6.0% during the forecast period. The growing demand for rehabilitative care, the growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease, and rapidly growing geriatric population; the subsequent increase in the global prevalence of chronic diseases is driving the growth of market. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65250228 In this report, the physiotherapy equipment market is segmented on the basis of product, application, end user, and region. Based on product, the physiotherapy equipment market is divided into two major segments, namely, equipment and accessories. The equipment segment accounted for the largest share of the physiotherapy equipment market in 2021. Market growth is largely driven by factors such as the rapidly aging population, the growing adoption of healthier lifestyle habits, as well as the increasing incidence of injuries and chronic diseases. The equipment segment is further segmented into electrotherapy equipment, ultrasound equipment, exercise therapy equipment, heat therapy equipment, cryotherapy equipment, combination therapy equipment, continuous passive motion therapy equipment, shockwave therapy equipment, laser therapy equipment, magnetic pressure therapy equipment, traction therapy, and other physiotherapy equipment (hydrotherapy and vacuum therapy). Electrotherapy equipment dominates the market with a share of about 25.6% in 2021, owing to their significant use in the treatment of musculoskeletal conditions with minimal/no side effects. Based on the application, the physiotherapy equipment market is segmented into musculoskeletal applications, neurological applications, cardiovascular and pulmonary applications, pediatric applications, gynecological applications, and other applications (including sports and palliative care). In 2021, the musculoskeletal applications segment accounted for the largest share of physiotherapy equipment market, which can be attributed to the rising incidence of musculoskeletal disorders, growth in the geriatric population, and the increasing number of accidents. Based on End User, the physiotherapy equipment market is segmented into physiotherapy & rehabilitation centers, hospitals, home care settings, physician offices, and other end users (community health centers and elderly care facilities). In 2021, physiotherapy & rehabilitation centers accounted for the largest share of the physiotherapy equipment market. This can primarily be attributed to the wide usage of physiotherapy equipment in these centers and the increased availability of specialized physiotherapists in such facilities. In 2021, Europe accounted for the largest share of the global physiotherapy equipment market. The large share of this regional segment can be attributed to the rising geriatric population, increasing inclination for active lifestyles, the penetration of physiotherapy services, and favorable healthcare reforms. The Asia Pacific market is projected to register the highest CAGR during the forecast period. Market growth in the Asia Pacific is attributed to the growth in emerging markets such as China and India, that are expected to present significant growth opportunities for the major stakeholders in the physiotherapy market. Additionally, increasing healthcare awareness and growing number of healthcare facilities in Asian countries are also the key factors supporting the market growth. Major Companies: Colfax Corp. (US), BTL Industries (UK), Performance Health (US), ITO Co., Ltd. (Japan), Enraf-Nonius B.V. (Netherlands), Dynatronics Corporation (US), Mectronic Medicale (Italy), EMS Physio Ltd. (UK), Whitehall Manufacturing (US), Zimmer MedizinSysteme GmbH (Germany), Zynex Inc, (US), Richmar (US), Life Care Systems (India), Storz Medical AG (Germany), Mettler Electronics Corp (US), Algeos (UK), Gymna (Belgium), Astar (Poland), HMS Medical Systems (India), Embitron s.r.o (Czech Republic), Proxomed (Germany), Tecnobody (Italy), Johari Digitals (India), Power Medic (Denmark), and CoolSystems Inc. (US) Recent Developments of Physiotherapy Equipment Industry In February 2022, Colfax Corp (US), announced the renewal of the partnership with Professional Football Athletic Trainer Society (PFATS, US), that allowed the company to endorse and recommend its products to certified athletic trainers. In January 2022, BTL Industries (UK) acquired Schepp MedTech (US). This acquisition was carried out for robots to enhance BTL's already very complex physiotherapy product portfolio. In January 2022, Zynex, Inc. (US) announced the launch of Post-operative and OA (Osteoarthritis) knee braces. The Knee braces can limit the wear and tear on the affected joint, enabling inflammation to settle and reduce pain/degeneration of the affected knee joint and thereby delaying or minimizing the need for surgery. In January 2021, Dynatronic Corporation (US) launched a new bariatric stand-in table with a motorized patient lift and an H-brace treatment table.
-
Brussels vacation packages from USA Discover the charm and elegance of Belgium's capital with our exclusive Brussels vacation packages from the USA. Experience the rich history, stunning architecture, and vibrant culture that make Brussels a must-visit destination. From the iconic Grand Place to the world-renowned Atomium, immerse yourself in the city's unique blend of old-world charm and modern allure. Indulge in delicious Belgian chocolates, waffles, and a wide array of local delicacies. Book your dream getaway to Brussels today and explore the heart of Europe with Trekhops! https://trekhops.com/tour-packages/brussels
-
Market Surge: Radiotherapy Expected to Hit $8.8 Billion by 2028 https://www.marketsandmarkets.com/Market-Reports/radiotherapy-monitoring-devices-market-567.html The global radiotherapy market is valued at USD 6.9 billion in 2023 and is expected to reach USD 8.8 billion by 2028, at a CAGR of 5.0% during the forecast period. The expanding prevalence of cancer worldwide and the rising aging population has increased the demand for advanced and non-invasive cancer treatment. According to National Institute of Health (NIH), approximately 1,958,310 new cancer cases are expected to be registered in US by end of 2023. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567 Radiotherapy Market by Type (Product, Service), Technology(MRI LINAC, Stereotactic, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT, 3D-CRT, LDR, HDR), Application (Prostate, Breast, Lung), End User (Hospital) - Global Forecast to 2028 Rising technological advancements in radiotherapy systems and software are playing a significant role in offering precise and personalized cancer treatment. Additionally, investments in oncology research activities by public & private organizations and initiatives by government to enhance the accessibility of radiotherapy devices are likely to contribute towards the significant growth of market during the forecast period. However, high cost associated with device procurement , limited financial budget, lack of health insurance coverage and inadequate healthcare infrastructure in low-income countries are likely to hinder the growth of radiotherapy market during the forecast period. On the basis of type, the radiotherapy market is segmented into products and software & services. The products segment accounted for the largest share of radiotherapy market in 2023. Whereas the software & services segment is anticipated to register a significant growth rate from 2023-2028. This is attributed to the adoption of treatment planning softwares allowing more precise and optimized radiation dose delivery. On the basis of technology, the radiotherapy market is segmented into external beam radiotherapy (further divided into linear accelerators, particle therapy systems, and conventional cobalt-60 teletherapy units, internal beam radiotherapy/brachytherapy (further segmented into seeds, applicators, after loaders, and IORT systems), and systemic radiotherapy products (including includes iobenguane (I-131), samarium-153, rhenium-186, and other radioisotopes (Yttrium-90, Radium-223, Phosphorous-32, and Radio-labelled antibodies, among others). In 2022, linear accelerators, a sub-segment of external beam radiotherapy segment accounted for the largest market This is attributed to the increased capabilities of LINAC in delivering effective radiation dosage, growing usage of LINAC across developed and developing nations, growing awareness about the advancements associated with LINAC systems. Based on end user, the radiotherapy market has been segmented into hospitals and independent radiotherapy centers. The hospitals segment accounted for the largest share of the radiotherapy market in 2023. This is attributed to the rising number of cancer patients undergoing radiotherapy treatment in hospitals and budget allocation implemented government in developing nation with an aim to enhance healthcare infrastructure, including the upgrading of radiotherapy equipment in hospitals. The global radiotherapy market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share of the radiotherapy market in 2022, followed by Europe. The larger share of North America is attribute to the strong adoption of advanced radiotherapy technology, presence of market players and favorable reimbursement policy in the region. The radiotherapy market in Asia Pacific is anticipated to experience significant growth opportunities in coming years owing to the government support for the development and commercialization of advanced radiotherapy devices , increased healthcare infrastructure, and rising number of cancer patients propelling demand for radiotherapy services across Asia Pacific Countries the radiotherapy market was dominated by Siemens Healthineers AG (Germany), Varian Medical Systems, Inc. (US), Elekta (Sweden) Accuray Incorporated (US), IBA (Belgium), ViewRay Technologies, Inc. (US), Hitachi Ltd. (Japan), iCAD, Inc. (US), IsoRay, Inc. (US), , among others. Recent Developments of Radiotherapy Industry In October 2023, Accuray incorporated received approval of Tomo C radiation therapy system by the Chinese National Medical Products Administration (NMPA). In July 2023, IBA entered into partnership with Apollo Proton Cancer Centre (APCC) (India) to provide training to Oncologist on proton beam therapy In April 2022, Elekta and GE Healthcare entered into a global commercial collaboration agreement in the field of radiation oncology, enabling them to provide hospitals a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy